Observational cohort studies (assessed with NIH tool)a
|
---|
|
Q1
|
Q2
|
Q3
|
Q4
|
Q5
|
Q6
|
Q7
|
Q8
|
Q9
|
Q10
|
Q11
|
Q12
|
Q13
|
Q14
|
Scoreb
|
---|
Ainsworth et al. [28]
|
2
|
2
|
2
|
2
|
1
|
2
|
2
|
0
|
0
|
0
|
2
|
0
|
2
|
1
|
18/28
|
Rein et al. [29]
|
2
|
2
|
2
|
2
|
1
|
2
|
2
|
0
|
0
|
2
|
0
|
0
|
2
|
1
|
18/28
|
Gokmen et al. [25]
|
2
|
0
|
2
|
2
|
1
|
2
|
2
|
2
|
2
|
2
|
0
|
2
|
2
|
1
|
22/28
|
Singh et al. [32]
|
2
|
2
|
2
|
2
|
1
|
2
|
2
|
2
|
2
|
2
|
0
|
1
|
2
|
1
|
23/28
|
Al-Ammouri et al. [33]
|
2
|
2
|
2
|
2
|
1
|
2
|
2
|
0
|
0
|
0
|
2
|
1
|
2
|
1
|
19/28
|
Minocha et al. [26]
|
2
|
2
|
2
|
2
|
1
|
2
|
2
|
2
|
2
|
1
|
2
|
1
|
2
|
1
|
24/28
|
Cross-sectional studies (assessed with NIH tool)
|
Azhar et al. [24]
|
2
|
2
|
2
|
2
|
1
|
2
|
2
|
2
|
2
|
2
|
0
|
2
|
2
|
1
|
24/28
|
Mackie et al. [30]
|
2
|
2
|
2
|
2
|
1
|
2
|
2
|
2
|
2
|
0
|
2
|
2
|
2
|
1
|
24/28
|
Mirzarahimi et al. [31]
|
2
|
2
|
2
|
0
|
1
|
2
|
2
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
15/28
|
Fenster et al. [34]
|
2
|
2
|
2
|
2
|
1
|
2
|
2
|
1
|
2
|
1
|
2
|
1
|
2
|
1
|
23/28
|
Case reports (assessed with NIH tool)
|
|
Q1
|
Q2
|
Q3
|
Q4
|
Q5
|
Q6
|
Q7
|
Q8
|
Q9
|
Score
| |
Ceresnak et al. [35]
|
2
|
2
|
2
|
0
|
2
|
2
|
2
|
1
|
2
|
15/18
| |
Paech et al. [36]
|
2
|
2
|
2
|
0
|
2
|
2
|
2
|
1
|
2
|
15/18
| |
- aTwo assessors rated each study. In the instance of a dispute, a third assessor was involved and a consensus was reached by majority
- bScoring system: 2 = yes; 1 = unclear or not applicable; 0 = no.
- Abbreviations: NIH, National Institutes of Health